Intensive insulin therapy is good value, say researchers.
出版信息
Am J Health Syst Pharm. 1997 Jan 15;54(2):116. doi: 10.1093/ajhp/54.2.116.
PMID:9117799
Abstract
摘要
相似文献
1
Intensive insulin therapy is good value, say researchers.
Am J Health Syst Pharm. 1997 Jan 15;54(2):116. doi: 10.1093/ajhp/54.2.116.
2
Role of Devices in Insulin Delivery.设备在胰岛素给药中的作用。
Diabetes Technol Ther. 2017 Feb;19(2):76-78. doi: 10.1089/dia.2017.0011.
3
Whither inhaled insulin?吸入式胰岛素何去何从？
Nat Clin Pract Endocrinol Metab. 2006 Aug;2(8):413. doi: 10.1038/ncpendmet0264.
4
Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers.将糖尿病控制与并发症试验（DCCT）转化为临床实践：克服障碍。
Diabetologia. 1997 Jul;40 Suppl 2:S88-90. doi: 10.1007/s001250051414.
5
Hypoglycaemia: costs, insulins and prevention.低血糖：成本、胰岛素与预防
Diabet Med. 2016 Apr;33(4):419-20. doi: 10.1111/dme.13100.
6
Hypoglycaemia, analogue insulins; prescribing cost or quality of life?低血糖、胰岛素类似物；处方成本还是生活质量？
Diabet Med. 2012 Mar;29(3):289. doi: 10.1111/j.1464-5491.2012.03583.x.
7
Long-acting insulin analogs versus human insulins.长效胰岛素类似物与人胰岛素的比较。
Diabetes Technol Ther. 2008 Oct;10(5):331-2. doi: 10.1089/dia.2008.0071.
8
Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?在英国可靠地评估持续皮下胰岛素输注与每日多次注射胰岛素的成本效益：存在哪些问题？
Diabet Med. 2007 Oct;24(10):1058-9. doi: 10.1111/j.1464-5491.2007.02284.x.
9
A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.传感器增强型胰岛素泵治疗和自动胰岛素暂停与 1 型糖尿病低血糖无知患者的标准泵治疗的成本效益分析。
Value Health. 2014 Jul;17(5):561-9. doi: 10.1016/j.jval.2014.05.008. Epub 2014 Jul 15.
10
[My quality of life has increased with Lantus].
Lakartidningen. 2004 Sep 23;101(39):3015; discussion 3016.
Zotero 插件